AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION for AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Advocate against legislation to repeal excise tax on indoor tanning services. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Health Issues HCR
Advocate for improved access to specialty drugs for patients with chronic conditions (H.R. 1600, Patients' Access to Treatments Act of 2015). Lobby Members of Congress to join the Congressional Skin Cancer Caucus. Lobby Congress to provide oversight of implementation of Public Law 113-54, the Drug Quality and Security Act, intended to protect and preserve the in-office use of compounded pharmaceuticals without a patient prescription. Advocate for legislation that would allow for Flexible Spending Accounts (FSAs) to be used to cover over-the-counter (OTC) drugs (S. 709, H.R. 1270, Restoring Access to Medication Act). Lobby Congress to provide oversight of implementation of Public Law 113-195, the Sunscreen Innovation Act, intended to create a transparent and predictable review process for sunscreen ingredients. Lobby Congress on issues related to telemedicine. Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Medicare/Medicaid MMM
Advocate for adequate and accurate network coverage for dermatologic care within Medicare Advantage and health insurance exchange networks. Support legislation to eliminate the Independent Payment Advisory Board (S.141, H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015). Lobby in support of legislation to enact a permanent repeal to the Medicare sustainable growth rate (H.R. 2, Medicare Access and CHIP Reauthorization Act ). Lobby in support of legislation to rescind or delay policy in the 2015 Final Medicare Physician Fee Schedule Rule to transition 10- and 90-day global period codes to 0-day global period codes in 2017 and 2018. (H.R. 2 Medicare Access and CHIP Reauthorization Act ). Lobby in support of increased transparency and adequate response time from CMS when setting values for misvalued codes. Advocate on issues related to waste, fraud and abuse in Medicare Advocate for increased funding and reforms to Graduate Medical Education. Lobby Congress on impact of Health Information Technology. Lobby Congress in opposition to repeal of the in-office ancillary and physician services exception for anatomic pathology services. Lobby Congress on issues related to telemedicine and Medicare reimbursement. Advocate on use and availability of health care data. Lobby in support of legislation to extend the 90 day reporting period for demonstration meaningful use in 2015 (H.R. 270, Flexibility in Health IT Reporting (Flex-IT) Act) Advocate for EHR interoperability with clinical data registries for quality improvement purposes. Lobby in support of legislation to require the Secretary of Health and Human Services to issue guidance on the application of the Common Rule to clinical data registries (H.R. 965, Facilitating Participation in Clinical Data Registries Act of 2015). Advocate regarding CMS global payment proposal, data registry issues, electronic health record and Medicare policies in 21st Century cures initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Medical/Disease Research/Clinical Labs MED
Advocate for strengthening and improving biomedical research, discovery and technological approval processes in the 21st Century Cures Initiative and Innovation for Healthier Americans. Advocate for medical research funding at the National Institutes of Health, National Cancer Institute, NIAMS, Centers for Disease Control and Prevention, and Food and Drug Administration (FY 16 Labor/HHS/Education Appropriations and FY 16 Agriculture Appropriations program request). Support legislation to adjust discretionary spending caps for biomedical research (S. 318/H.R. 531, Accelerating Biomedical Research Act; S. 289, American Cures Act) Advocate for reforms to NIH and FDA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Torts TOR
Advocate for legislation to enact medical liability reforms. Support inclusion of standard of care provisions in H.R. 2, Medicare Access and CHIP Reauthorization Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHAWN FRIESEN | — |
| KATIE JONES | — |
| NIVA MURRAY | — |
| CHRISTINE O'CONNOR | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.